Vaccine Helps Prevent HSV-1 Genital Disease and Infection
An investigational vaccine effectively prevents herpes simplex virus type 1 (HSV-1) but not HSV type 2 (HSV-2) genital disease and infection.
Diagnosis & Disease Information
Oseltamivir-Resistant H1N1 Identified in Australia
Oseltamivir-resistant prepandemic seasonal influenza 1 (H1N1) viruses with a neuraminidase substitution (H275Y) (A[H1N1]pdm09) have been identified in Australia.
CDC Outlines HPV and Hep B Vaccine Recommendations
Vaccination against human papillomavirus (HPV) in young males and hepatitis B in adults with diabetes mellitus is recommended by the Advisory Committee on Immunization Practices (ACIP) for infection control.
Isentress Gains Expanded Indication for Children with HIV-1
Isentress (raltegravir; Merck) has been approved by the FDA for use with other antiretroviral drugs for the treatment of HIV-1 infection for children 2-18 years, weighing ≥10kg.
NDA Submitted for Crofelemer for HIV-Associated Diarrhea
Salix announced that it has submitted a New Drug Application (NDA) to the FDA for crofelemer for the treatment of HIV-associated diarrhea.
Phase 3 Study of Elvitegravir for HIV-1 Infection
Gilead Sciences announced data from its Phase 3 (Study 145) trial of elvitegravir for the treatment of HIV-1 infection.
Intranasal Vaccine Effective Against Norwalk Virus Illness
Two doses of an intranasally delivered norovirus virus-like particle (VLP) vaccine with adjuvants (chitosan and monophosphoryl lipid A), provides protection against challenge with a homologous Norwalk virus in healthy adults, according to a study published in the Dec. 8 issue of the New England Journal of Medicine.
Phase 3 Study of Cobicistat as a Boosting Agent in HIV
Gilead Sciences announced results from its Phase 3 (Study 114) study of cobicistat as a pharmaco-enhancing or “boosting” agent in the treatment of HIV.
Mylan’s Atazanavir/Ritonavir Tablets Garner Tentative FDA Approval Through PEPFAR
Mylan announced that the FDA has granted tentative approval through the President’s Emergency Plan for AIDS Relief (PEPFAR)for its heat-stable atazanavir sulfate/ritonavir tablets for the treatment of HIV infection and AIDS.
Cold-EEZE Oral Spray Available
ProPhase Labs has expanded the Cold-EEZE product line with Cold-EEZE Oral Spray to reduce the severity and duration of the common cold.
